✦ LIBER ✦

PIH17 Cost-Effectiveness Analysis of Anti-Pneumococcal Vaccination in High Risk and Adult Patients in Ecuador

✍ Scribed by Albuja Riofrio, M.F.; Vivero Altamirano, R.L.; Mould Quevedo, J.F.; Roberts, C.S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PIN22 COST OF PNEUMOCOCCAL INFECTIONS AN

✍ L Akin; M Kaya; S Altinel; T Pehlivan; L Durand; A Tasset-Tisseau 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Potential cost-effectiveness and benefit

✍ Alexander Kuhlmann, Ulrike Theidel, Mathias W Pletz, J-Matthias Graf von der Sch 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 500 KB

PIN7 COST-Effectiveness Analysis Of Anti

✍ Dueñas, M.D.L.; Lutz, M; Morales, G.; Strutton, D.R.; Roberts, C.; Cuesta, G.; F 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Cost-Effectiveness Analysis Of Pneumococ

✍ Liu, G.; Zhu, L.; Deng, J.; Fu, Y.; Chu, Y.; Jin, X.; Shi, Q. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Cost-effectiveness analysis of pneumococ

✍ A. Melegaro; W.J. Edmunds 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 349 KB

PIN63 Cost-Effectiveness Analysis of Ant

✍ M.A. Lutz; K. Luciani; G. Morales; D.R. Strutton; C.S. Roberts; R.A. Farkouh; G. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB